Company: DAWN
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0000950170-25-103012
Chunk: 3

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Item 5
Chunk 3
---
Insider Trading Policies and Arrangements

The Company’s directors and Section 16 officers (as defined in Rule 16a-1(f) under the Exchange Act) are only permitted to trade in the Company’s securities pursuant to a prearranged trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act, or a Rule 10b5-1 Plan. During the three months ended June 30, 2025, none of the Company’s Section 16 officers or directors adopted or terminated any Rule 10b5-1 Plan.